Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to trastuzumab in HER2-amplified breast cancer

Detalles Bibliográficos
Autores principales: Gijsen, M, King, P, Perera, T, Parker, P, Larijani, B, Harris, A, Kong, A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875558/
http://dx.doi.org/10.1186/bcr2493
Descripción
Sumario:

Ejemplares similares